Details
Stereochemistry | ACHIRAL |
Molecular Formula | C10H12O3 |
Molecular Weight | 180.2005 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCOC(=O)C1=CC=C(O)C=C1
InChI
InChIKey=QELSKZZBTMNZEB-UHFFFAOYSA-N
InChI=1S/C10H12O3/c1-2-7-13-10(12)8-3-5-9(11)6-4-8/h3-6,11H,2,7H2,1H3
Molecular Formula | C10H12O3 |
Molecular Weight | 180.2005 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: http://www.fda.gov/cosmetics/productsingredients/ingredients/ucm128042.htm#What_are_parabensCurator's Comment: Description was created based on several sources, including
http://www.ncbi.nlm.nih.gov/pubmed/24542410;
http://www.ncbi.nlm.nih.gov/pubmed/576658;
http://www.ukfoodguide.net/e216.htm
Sources: http://www.fda.gov/cosmetics/productsingredients/ingredients/ucm128042.htm#What_are_parabens
Curator's Comment: Description was created based on several sources, including
http://www.ncbi.nlm.nih.gov/pubmed/24542410;
http://www.ncbi.nlm.nih.gov/pubmed/576658;
http://www.ukfoodguide.net/e216.htm
Propylparaben is a bacteriostatic and fungistatic agent used as a preservative in cosmetic products, food and drugs. As a food additive, it has the E number E216. To increase the activity and reduce its dose propylparaben is used in a mixture with other parabens and in combination with other types of preservatives. Propylparaben is a chemical allergen capable of producing immunologically mediated hypersensitivity reactions. Chemically it is an ester of p-hydroxybenzoic acid.
Approval Year
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Inactive ingredient | XILAPAK Approved UseFor the management of hypertrophic tissues, keloid tissues, dermatitis and dermatoses Launch Date2017 |
|||
Preventing | Iscaguard® FPX2 Approved UseUnknown |
|||
Preventing | Iscaguard® FPX2 Approved UseUnknown |
|||
Preventing | Iscaguard® FPX2 Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
In vivo and in vitro estrogen bioactivities of alkyl parabens. | 2003 Jul |
|
Separation of preservatives in cosmetic products by micellar electrokinetic chromatography. | 2004 Dec |
|
[Synthesis of new mandelic acid derivatives with preservative action. Synthesis and acute toxicity study]. | 2004 Jan-Mar |
|
[In vitro susceptibility of a Staphylococcus spp. isolate to food preservatives]. | 2004 Oct-Dec |
|
Morphometric analysis of mice uteri treated with the preservatives methyl, ethyl, propyl, and butylparaben. | 2004 Sep |
|
HPLC analysis of generic antiretroviral drugs purchased in Rwanda. | 2005 |
|
In vitro effect of phenolic antioxidants on germination, growth and aflatoxin B accumulation by peanut Aspergillus section Flavi. | 2005 |
|
High performance liquid chromatographic determination of oxeladin citrate and oxybutynin hydrochloride and their degradation products. | 2005 Aug |
|
The effects of parabens on the mechanosensitive channels of E. coli. | 2005 Jul |
|
A novel gradient HPLC method for simultaneous determination of ranitidine, methylparaben and propylparaben in oral liquid pharmaceutical formulation. | 2005 Jul 15 |
|
Liquid chromatography and chemometric-assisted spectrophotometric methods for the analysis of two multicomponent mixtures containing cough suppressant drugs. | 2005 Jul-Aug |
|
A review of the endocrine activity of parabens and implications for potential risks to human health. | 2005 Jun |
|
Propyl paraben induces potassium efflux in Escherichia coli. | 2005 Jun |
|
Decrease in skin permeation and antibacterial effect of parabens by a polymeric additive, poly(2-methacryloyloxyethyl phosphorylcholine-co-butylmetacrylate). | 2005 Mar |
|
The use of colloidal microgels as a (trans)dermal drug delivery system. | 2005 Mar 23 |
|
Development and validation of a stability indicating HPLC method for determination of lisinopril, lisinopril degradation product and parabens in the lisinopril extemporaneous formulation. | 2005 Mar 9 |
|
Simultaneous determination of preservatives (benzoic acid, sorbic acid, methylparaben and propylparaben) in foodstuffs using high-performance liquid chromatography. | 2005 May 6 |
|
Rapid and sensitive determination of indapamide in human blood by liquid chromatography with electrospray ionization mass spectrometric detection: application to a bioequivalence study. | 2005 Nov |
|
A new validated method for the simultaneous determination of benzocaine, propylparaben and benzyl alcohol in a bioadhesive gel by HPLC. | 2005 Oct 4 |
|
Determination of parabens in pharmaceutical formulations by solid-phase microextraction-ion mobility spectrometry. | 2005 Sep 15 |
|
Stability indicating reversed-phase liquid chromatographic determination of metronidazole benzoate and diloxanide furoate as bulk drug and in suspension dosage form. | 2005 Sep 15 |
|
A comparison of performance of various analytical columns in pharmaceutical analysis: conventional C18 and high throughput C18 zorbax columns. | 2005 Sep 23 |
|
The importance of the cosolvent propylene glycol on the antimicrobial preservative efficacy of a pharmaceutical formulation by DOE-ruggedness testing. | 2006 |
|
Application of ecotoxicogenomics for studying endocrine disruption in vertebrates and invertebrates. | 2006 Apr |
|
Causal agents of photoallergic contact dermatitis diagnosed in the national institute of dermatology of Colombia. | 2006 Aug |
|
Parabens as urinary biomarkers of exposure in humans. | 2006 Dec |
|
Evaluation of xenoestrogenic potential of propylparaben in zebrafish (Danio rerio). | 2006 Dec |
|
Effect of formulation factors on in-vitro permeation of diclofenac from experimental and marketed aqueous eye drops through excised goat cornea. | 2006 Dec |
|
Separation and determination of clotrimazole, methylparaben and propylparaben in pharmaceutical preparation by micellar electrokinetic chromatography. | 2006 Jan 23 |
|
Simultaneous analysis of antioxidants and preservatives in cosmetics by supercritical fluid extraction combined with liquid chromatography-mass spectrometry. | 2006 Jul 7 |
|
Simultaneous, stability indicating, HPLC-DAD determination of guaifenesin and methyl and propyl-parabens in cough syrup. | 2006 Jun 7 |
|
A stability-indicating HPLC method for medroxyprogesterone acetate in bulk drug and injection formulation. | 2006 Mar 18 |
|
Expression profiling of estrogen-responsive genes in breast cancer cells treated with alkylphenols, chlorinated phenols, parabens, or bis- and benzoylphenols for evaluation of estrogenic activity. | 2006 May 25 |
|
HPLC determination of calcium pantothenate and two preservatives in topical cream. | 2006 May 3 |
|
Stability indicating simultaneous determination of domperidone (DP), methylparaben (MP) and propylparaben by high performance liquid chromatography (HPLC). | 2006 May 3 |
|
Application and validation of chemometrics-assisted spectrophotometry and liquid chromatography for the simultaneous determination of six-component pharmaceuticals. | 2006 May 3 |
|
Development and validation of a simple reversed-phase high-performance liquid chromatography method for the determination of testosterone in serum of males. | 2006 May 3 |
|
Pharmaceutical excipients and the information on drug labels. | 2006 May-Jun |
|
The influence of physicochemical properties of preservative compounds on their distribution into various phases of oil in water submicron emulsion. | 2006 May-Jun |
|
Simple determination of betamethasone and chloramphenicol in a pharmaceutical preparation using a short monolithic column coupled to a sequential injection system. | 2006 Nov |
|
Advantages of ultra performance liquid chromatography over high-performance liquid chromatography: comparison of different analytical approaches during analysis of diclofenac gel. | 2006 Nov |
|
Prediction of estrogen receptor agonists and characterization of associated molecular descriptors by statistical learning methods. | 2006 Nov |
|
Solid-phase extraction and HPLC analysis of methylparaben and propylparaben in a concentrated antibiotic suspension. | 2006 Oct |
|
Flow cytometric cell cycle analysis allows for rapid screening of estrogenicity in MCF-7 breast cancer cells. | 2006 Oct |
|
Development and validation of chemometrics-assisted spectrophotometric and liquid chromatographic methods for the simultaneous determination of two multicomponent mixtures containing bronchodilator drugs. | 2007 Feb 19 |
|
Effect estimates and methodological quality of randomized controlled trials about prevention of alveolar osteitis following tooth extraction: a systematic review. | 2007 Jan |
|
Controlled drug release from pellets containing water-insoluble drugs dissolved in a self-emulsifying system. | 2007 Jan |
|
Assay of artemether, methylparaben and propylparaben in a formulated paediatric antimalarial dry suspension. | 2007 Jan 17 |
|
Post-marketing assessment of content and efficacy of preservatives in artemisinin-derived antimalarial dry suspensions for paediatric use. | 2007 Jan 26 |
|
Comparison of objective and sensory skin irritations of several cosmetic preservatives. | 2007 Mar |
Patents
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:22:02 GMT 2023
by
admin
on
Fri Dec 15 15:22:02 GMT 2023
|
Record UNII |
Z8IX2SC1OH
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C92608
Created by
admin on Fri Dec 15 15:22:02 GMT 2023 , Edited by admin on Fri Dec 15 15:22:02 GMT 2023
|
||
|
NDF-RT |
N0000185508
Created by
admin on Fri Dec 15 15:22:02 GMT 2023 , Edited by admin on Fri Dec 15 15:22:02 GMT 2023
|
||
|
CFR |
21 CFR 184.1670
Created by
admin on Fri Dec 15 15:22:02 GMT 2023 , Edited by admin on Fri Dec 15 15:22:02 GMT 2023
|
||
|
CFR |
21 CFR 172.515
Created by
admin on Fri Dec 15 15:22:02 GMT 2023 , Edited by admin on Fri Dec 15 15:22:02 GMT 2023
|
||
|
EU FOOD ADDITIVES |
E-216
Created by
admin on Fri Dec 15 15:22:02 GMT 2023 , Edited by admin on Fri Dec 15 15:22:02 GMT 2023
|
||
|
EPA PESTICIDE CODE |
61203
Created by
admin on Fri Dec 15 15:22:02 GMT 2023 , Edited by admin on Fri Dec 15 15:22:02 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
SUB12242MIG
Created by
admin on Fri Dec 15 15:22:02 GMT 2023 , Edited by admin on Fri Dec 15 15:22:02 GMT 2023
|
PRIMARY | |||
|
8511
Created by
admin on Fri Dec 15 15:22:02 GMT 2023 , Edited by admin on Fri Dec 15 15:22:02 GMT 2023
|
PRIMARY | |||
|
23515
Created by
admin on Fri Dec 15 15:22:02 GMT 2023 , Edited by admin on Fri Dec 15 15:22:02 GMT 2023
|
PRIMARY | |||
|
DB14177
Created by
admin on Fri Dec 15 15:22:02 GMT 2023 , Edited by admin on Fri Dec 15 15:22:02 GMT 2023
|
PRIMARY | |||
|
202-307-7
Created by
admin on Fri Dec 15 15:22:02 GMT 2023 , Edited by admin on Fri Dec 15 15:22:02 GMT 2023
|
PRIMARY | |||
|
Z8IX2SC1OH
Created by
admin on Fri Dec 15 15:22:02 GMT 2023 , Edited by admin on Fri Dec 15 15:22:02 GMT 2023
|
PRIMARY | |||
|
7175
Created by
admin on Fri Dec 15 15:22:02 GMT 2023 , Edited by admin on Fri Dec 15 15:22:02 GMT 2023
|
PRIMARY | |||
|
C76730
Created by
admin on Fri Dec 15 15:22:02 GMT 2023 , Edited by admin on Fri Dec 15 15:22:02 GMT 2023
|
PRIMARY | |||
|
N0000175629
Created by
admin on Fri Dec 15 15:22:02 GMT 2023 , Edited by admin on Fri Dec 15 15:22:02 GMT 2023
|
PRIMARY | Increased Histamine Release [PE] | ||
|
SUB169805
Created by
admin on Fri Dec 15 15:22:02 GMT 2023 , Edited by admin on Fri Dec 15 15:22:02 GMT 2023
|
PRIMARY | |||
|
PROPYLPARABEN
Created by
admin on Fri Dec 15 15:22:02 GMT 2023 , Edited by admin on Fri Dec 15 15:22:02 GMT 2023
|
PRIMARY | Description: Colourless crystals or a white, crystalline powder; odourless or with a faintly aromatic odour. Solubility: Very slightly soluble in water; slightly soluble in boiling water; freely soluble in ethanol (~750 g/l) TS and ether R. Category: Antimicrobial preservative. Storage: Propyl hydroxybenzoate should be kept in a well-closed container. Additional information: Propyl hydroxybenzoate is normally used in combination with other hydroxybenzoates. Requirement: Propyl hydroxybenzoate contains not less than 99.0% and not more than the equivalent of 101.0% of C10H12O3, calculated withreference to the dried substance. | ||
|
m9247
Created by
admin on Fri Dec 15 15:22:02 GMT 2023 , Edited by admin on Fri Dec 15 15:22:02 GMT 2023
|
PRIMARY | Merck Index | ||
|
PROPYLPARABEN
Created by
admin on Fri Dec 15 15:22:02 GMT 2023 , Edited by admin on Fri Dec 15 15:22:02 GMT 2023
|
PRIMARY | |||
|
Y-36
Created by
admin on Fri Dec 15 15:22:02 GMT 2023 , Edited by admin on Fri Dec 15 15:22:02 GMT 2023
|
PRIMARY | |||
|
1577008
Created by
admin on Fri Dec 15 15:22:02 GMT 2023 , Edited by admin on Fri Dec 15 15:22:02 GMT 2023
|
PRIMARY | |||
|
100000079299
Created by
admin on Fri Dec 15 15:22:02 GMT 2023 , Edited by admin on Fri Dec 15 15:22:02 GMT 2023
|
PRIMARY | |||
|
N0000171131
Created by
admin on Fri Dec 15 15:22:02 GMT 2023 , Edited by admin on Fri Dec 15 15:22:02 GMT 2023
|
PRIMARY | Allergens [Chemical/Ingredient] | ||
|
N0000184306
Created by
admin on Fri Dec 15 15:22:02 GMT 2023 , Edited by admin on Fri Dec 15 15:22:02 GMT 2023
|
PRIMARY | Cell-mediated Immunity [PE] | ||
|
2307
Created by
admin on Fri Dec 15 15:22:02 GMT 2023 , Edited by admin on Fri Dec 15 15:22:02 GMT 2023
|
PRIMARY | |||
|
203
Created by
admin on Fri Dec 15 15:22:02 GMT 2023 , Edited by admin on Fri Dec 15 15:22:02 GMT 2023
|
PRIMARY | |||
|
94-13-3
Created by
admin on Fri Dec 15 15:22:02 GMT 2023 , Edited by admin on Fri Dec 15 15:22:02 GMT 2023
|
PRIMARY | |||
|
DTXSID4022527
Created by
admin on Fri Dec 15 15:22:02 GMT 2023 , Edited by admin on Fri Dec 15 15:22:02 GMT 2023
|
PRIMARY | |||
|
Z8IX2SC1OH
Created by
admin on Fri Dec 15 15:22:02 GMT 2023 , Edited by admin on Fri Dec 15 15:22:02 GMT 2023
|
PRIMARY | |||
|
32063
Created by
admin on Fri Dec 15 15:22:02 GMT 2023 , Edited by admin on Fri Dec 15 15:22:02 GMT 2023
|
PRIMARY | |||
|
34706
Created by
admin on Fri Dec 15 15:22:02 GMT 2023 , Edited by admin on Fri Dec 15 15:22:02 GMT 2023
|
PRIMARY | RxNorm | ||
|
C006068
Created by
admin on Fri Dec 15 15:22:02 GMT 2023 , Edited by admin on Fri Dec 15 15:22:02 GMT 2023
|
PRIMARY | |||
|
CHEMBL194014
Created by
admin on Fri Dec 15 15:22:02 GMT 2023 , Edited by admin on Fri Dec 15 15:22:02 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT | |||
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |